Project Details
Project Description
| Status | Active |
|---|---|
| Effective start/end date | 13/11/23 → 12/11/28 |
A Phase 2b, Randomized, Controlled Double-blind, Multicenter Study Comparing the Efficacy and Safety of Zetomipzomib (KZR-616) 30 mg or 60 mg with Placebo in Patients with Active Lupus Nephritis
- Ghali, Joanna (Primary Chief Investigator (PCI))
Project: Research